FDA finds repeat quality failures at Houston's Empower Pharmacy in latest inspection, records show

The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.
Becker's Hospital Review

Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access

Compounding pharmacy sues Eli Lilly and Novo Nordisk alleging antitrust violations to restrict compounded GLP-1 medication access and limit competition.
BioSpace

Compounder Sues Lilly, Novo, Claims Coordinated Crackdown

Strive Compounding Pharmacy alleged in its lawsuit that Eli Lilly and Novo Nordisk have worked to lock telehealth providers ...

Lilly, Novo sued over GLP‑1 drug dominance by compounding pharmacy

Drugmakers Eli Lilly and Novo Nordisk have been sued in Texas by a compounding pharmacy that alleges they are illegally ...